Poseida Therapeutics CEO Eric Ostertag's 2021 pay jumps 633% to $6.3M
Poseida Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 27, 2022
Poseida Therapeutics reported fiscal year 2021 executive compensation information on April 27, 2022.
In 2021, four executives at Poseida Therapeutics received on average a compensation package of $3.1M, a 214% increase compared to previous year.
Average pay of disclosed executives at Poseida Therapeutics
Eric Ostertag, Chief Executive Officer, received $6.3M in total, which increased by 633% compared to 2020. 89% of Ostertag's compensation, or $5.6M, was in option awards. Ostertag also received $218K in non-equity incentive plan, $440K in salary, as well as $9.3K in other compensation.
Mark J. Gergen, Chief Executive Officer, received a compensation package of $2.8M, which increased by 96% compared to previous year. 77% of the compensation package, or $2.2M, was in option awards.
Matthew A. Spear, Chief Medical Officer, earned $1.6M in 2021, a 168% increase compared to previous year.
Harry J. Leonhardt, General Counsel, received $1.4M in 2021.
Related executives
You may also like
Source: SEC filing on April 27, 2022.